| Gene symbol | TGFB2 | Synonyms | G-TSF, LDS4, TGF-beta2 | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1q41 | dbXrefs | |
| Description | transforming growth factor beta 2 | ||||
| GTO ID | GTC1862 |
| Trial ID | NCT03431311 |
| Disease | Colorectal Cancer |
| Altered gene | TGFB2 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | TGFbetaII TCR-T cells |
| HLA | HLA-A*02 |
| Phase | Phase1|Phase2 |
| Recruitment status | Terminated |
| Title | Protocol for Treatment Under Hospital Exemption: T Cell Receptor Based Therapy of Metastatic Colorectal Cancer With mRNA-engineered T Cells Targeting Transforming Growth Factor Beta Receptor Type II (TGFβII) |
| Year | 2018 |
| Country | Norway |
| Company sponsor | Oslo University Hospital |
| Other ID(s) | TCR-CRC-001 |
| Cohort 1 | |||||||
|
|||||||